Study Stopped
enrollment proceeding too slowly
Magnesium Sulfate Versus Placebo for Tocolysis in PPROM
1 other identifier
interventional
4
1 country
1
Brief Summary
Study compares the outcomes of women between 26 and 32 wks gestation with rupture of membranes. Women randomized to receive tocolysis with magnesium sulfate x 48 hrs or placebo of saline IV x 48 hrs. Antibiotics and antenatal steroids given to both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 19, 2007
CompletedFirst Posted
Study publicly available on registry
April 20, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedAugust 19, 2016
August 1, 2016
2.9 years
April 19, 2007
August 17, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hours of latency to delivery
from start of study drug to delivery
0 hours to > 168 hours
Secondary Outcomes (5)
maternal postpartum length of stay
0 hours to > 168 hours
maternal infection rates
0 hours to > 168 hours
neonatal ventilator days
0 to 28 days
neonatal early onset infection
0 to 28 days
neonatal length of stay
0 to 28 days
Study Arms (2)
Magnesium sulfate
ACTIVE COMPARATORx 48 hours IV
Normal saline
PLACEBO COMPARATORx 48 hours IV
Interventions
Eligibility Criteria
You may qualify if:
- English or Spanish speaking
- preterm premature rupture of membranes
- weeks gestation
- cervical dilation \</= 4 cm
You may not qualify if:
- suspected intrauterine or intraamniotic infection
- \> 6 hours of tocolysis prior to admission
- positive fetal lung maturity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Regional Obstetrical Consultants
Chattanooga, Tennessee, 37403, United States
Related Publications (1)
Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, Coomarasamy A, Tobias A, Chou D, Oladapo OT, Price MJ, Morris K, Gallos ID. Tocolytics for delaying preterm birth: a network meta-analysis (0924). Cochrane Database Syst Rev. 2022 Aug 10;8(8):CD014978. doi: 10.1002/14651858.CD014978.pub2.
PMID: 35947046DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian M Briery, MD
Regional Obstetrical Consultants; UT Chattanooga OB-GYN Department
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Christian Briery MD
Study Record Dates
First Submitted
April 19, 2007
First Posted
April 20, 2007
Study Start
April 1, 2007
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
August 19, 2016
Record last verified: 2016-08